## Pharmacotherapy Initiation When Behavioral Interventions Are Insufficient **Key Point:** When behavioral interventions and classroom accommodations alone fail to achieve adequate functional improvement over 4+ months, pharmacotherapy should be initiated as an adjunct — not delayed indefinitely. ### Criteria for Adding Medication to Behavioral Management | Criterion | Status in This Case | |-----------|--------------------| | Confirmed ADHD diagnosis | ✓ Yes (6 months prior) | | Adequate trial of behavioral intervention | ✓ Yes (4 months) | | Persistent functional impairment | ✓ Yes (homework, academics) | | Baseline medical clearance | ✓ Yes (normal vitals, weight, cardiac exam) | | Parental understanding of risks/benefits | To be done | | Baseline height, weight, BP documented | ✓ Yes | **High-Yield:** NEET PG emphasizes that stimulants (methylphenidate, amphetamine) are FIRST-LINE pharmacotherapy for ADHD when behavioral measures are insufficient — not atomoxetine or guanfacine. ### Stimulant vs. Non-Stimulant Comparison | Feature | Stimulants (Methylphenidate) | Atomoxetine | |---------|------------------------------|-------------| | **Onset of action** | 30 min–1 hr | 2–4 weeks | | **First-line status** | Yes | No (second-line) | | **Efficacy for ADHD core symptoms** | Superior | Moderate | | **Abuse potential** | Higher (Schedule II) | Lower | | **Cardiac monitoring** | Baseline ECG if risk factors | Baseline ECG if risk factors | | **Dosing frequency** | Once or twice daily | Once daily | **Clinical Pearl:** Stimulants are preferred despite higher abuse potential because: - Faster onset allows quicker assessment of efficacy - Superior symptom control in most children - Abuse risk is minimal in supervised pediatric populations - Atomoxetine is reserved for children with tic disorders, anxiety, or stimulant intolerance ### Management Algorithm: When to Start Medication ```mermaid flowchart TD A[Confirmed ADHD diagnosis]:::outcome --> B[Initiate behavioral intervention + school accommodations]:::action B --> C[Reassess after 4-6 weeks]:::decision C -->|Adequate response| D[Continue behavioral management]:::action C -->|Inadequate response| E[Trial duration ≥4 months?]:::decision E -->|No| F[Optimize behavioral strategies]:::action E -->|Yes| G[Baseline medical clearance]:::action G --> H[Initiate stimulant pharmacotherapy]:::action H --> I[Monitor response at 2-4 weeks]:::decision I -->|Good response| J[Continue & titrate as needed]:::action I -->|Poor response| K[Switch to non-stimulant or alternative]:::action ``` **Mnemonic: STIMULANT SAFETY — "HEART"** - **H**eight, weight baseline - **E**CG if cardiac risk factors - **A**ppetite, sleep monitoring - **R**ate (heart rate, BP) at each visit - **T**ic assessment (worsening?) [cite:Park 26e Ch 12]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.